Evidence map›Paper›PMID 25229236›Full record

ArticlePloS one2014

Results of the implementation of a pilot model for the bidirectional screening and joint management of patients with pulmonary tuberculosis and diabetes mellitus in Mexico.

Martín Castellanos-Joya, Guadalupe Delgado-Sánchez, Leticia Ferreyra-Reyes, Pablo Cruz-Hervert, Elizabeth Ferreira-Guerrero, Gabriela Ortiz-Solís, Mirtha Irene Jiménez, Leslie Lorena Salazar, Rogelio Montero-Campos, Norma Mongua-Rodríguez and 6 more

Abstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Martín Castellanos-JoyaDirección del Programa de Micobacteriosis, Centro Nacional de Programas Preventivos y Control de Enfermedades, México, Distrito Federal, México.
Guadalupe Delgado-SánchezCentro de Investigación sobre Enfermedades Infecciosas, Instituto Nacional de Salud Pública, Cuernavaca, Morelos, México.
Leticia Ferreyra-ReyesCentro de Investigación sobre Enfermedades Infecciosas, Instituto Nacional de Salud Pública, Cuernavaca, Morelos, México.
Pablo Cruz-HervertCentro de Investigación sobre Enfermedades Infecciosas, Instituto Nacional de Salud Pública, Cuernavaca, Morelos, México.
Elizabeth Ferreira-GuerreroCentro de Investigación sobre Enfermedades Infecciosas, Instituto Nacional de Salud Pública, Cuernavaca, Morelos, México.
Gabriela Ortiz-SolísDirección del Programa de Salud en el Adulto y en el Anciano, Centro Nacional de Programas Preventivos y Control de Enfermedades, México, Distrito Federal, México.
Mirtha Irene JiménezDirección del Programa de Micobacteriosis, Centro Nacional de Programas Preventivos y Control de Enfermedades, México, Distrito Federal, México.
Leslie Lorena SalazarDirección del Programa de Micobacteriosis, Centro Nacional de Programas Preventivos y Control de Enfermedades, México, Distrito Federal, México.
Rogelio Montero-CamposCentro de Investigación sobre Enfermedades Infecciosas, Instituto Nacional de Salud Pública, Cuernavaca, Morelos, México.
Norma Mongua-RodríguezCentro de Investigación sobre Enfermedades Infecciosas, Instituto Nacional de Salud Pública, Cuernavaca, Morelos, México.
Renata Baez-SaldañaCentro de Investigación sobre Enfermedades Infecciosas, Instituto Nacional de Salud Pública, Cuernavaca, Morelos, México.
Miriam Bobadilla-del-ValleLaboratorio de Microbiología, Instituto Nacional de Ciencias Médicas y de Nutrición "Salvador Zubirán", México, Distrito Federal, México.
Jesús Felipe González-RoldánDirección General, Centro Nacional de Programas Preventivos y Control de Enfermedades, México, Distrito Federal, México.
Alfredo Ponce-de-LeónLaboratorio de Microbiología, Instituto Nacional de Ciencias Médicas y de Nutrición "Salvador Zubirán", México, Distrito Federal, México.
José Sifuentes-OsornioDirección Médica, Instituto Nacional de Ciencias Médicas y de Nutrición "Salvador Zubirán", México, Distrito Federal, México.
Lourdes García-GarcíaCentro de Investigación sobre Enfermedades Infecciosas, Instituto Nacional de Salud Pública, Cuernavaca, Morelos, México.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecently, the World Health Organisation and the International Union Against Tuberculosis and Lung Disease published a Collaborative Framework for the Care and Control of Tuberculosis (TB) and Diabetes (DM) (CFTB/DM) proposing bidirectional screening and joint management.

objectiveTo evaluate the feasibility and effectiveness of the CFTB/DM in Mexico.

designProspective observational cohort.

setting15 primary care units in 5 states in Mexico.

participantsPatients aged ≥20 years diagnosed with DM or pulmonary TB who sought care at participating clinics.

interventionThe WHO/Union CFTB/DM was adapted and implemented according to official Mexican guidelines. We recruited participants from July 2012 to April 2013 and followed up until March 2014. Bidirectional screening was performed. Patients diagnosed with TB and DM were invited to receive TB treatment under joint management.

main outcome measuresDiagnoses of TB among DM, of DM among TB, and treatment outcomes among patients with DM and TB.

resultsOf 783 DM patients, 11 (1.4%) were unaware of their TB. Of 361 TB patients, 16 (4.4%) were unaware of their DM. 95 TB/DM patients accepted to be treated under joint management, of whom 85 (89.5%) successfully completed treatment. Multiple linear regression analysis with change in HbA1c and random capillary glucose as dependent variables revealed significant decrease with time (regression coefficients (β)  = -0.660, (95% confidence interval (CI), -0.96 to -0.35); and β = -1.889 (95% CI, -2.77 to -1.01, respectively)) adjusting by sex, age and having been treated for a previous TB episode. Patients treated under joint management were more likely to experience treatment success than patients treated under routine DM and TB programs as compared to historical (adjusted OR (aOR), 2.8, 95%CI 1.28-6.13) and same period (aOR 2.37, 95% CI 1.13-4.96) comparison groups.

conclusionsJoint management of TB and DM is feasible and appears to improve clinical outcomes.

Indexed as

AgedDiabetes MellitusDisease ManagementHumansMexicoMiddle AgedProspective StudiesTuberculosis, Pulmonary

Identifiers

PMID25229236
PMCPMC4167852

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.